We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$4.49B
AUM Growth
+$274M
Cap. Flow
-$202M
Cap. Flow %
-4.5%
Top 10 Hldgs %
17.39%
Holding
140
New
5
Increased
37
Reduced
95
Closed
3

Top Buys

Rank Stock Value
1
EHTH icon
eHealth
EHTH
+$21.7M
2
BOX icon
Box
BOX
+$18.8M
3
CHRS icon
Coherus Oncology
CHRS
+$5.41M
4
HQY icon
HealthEquity
HQY
+$4.81M
5
FANG icon
Diamondback Energy
FANG
+$4.62M

Sector Composition

Rank Sector Weight
1 Industrials 22.3%
2 Technology 17.03%
3 Healthcare 15.26%
4 Financials 14.45%
5 Consumer Discretionary 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIN icon
26
Albany International
AIN
$2.11B
$52.6M 1.17%
629,936
-121,753
-16% -$9.66M
KRA
27
DELISTED
Kraton Corporation
KRA
$49.4M 1.1%
1,351,107
-63,434
-4% -$2.27M
CAI
28
DELISTED
CAI International, Inc.
CAI
$48.3M 1.07%
1,060,966
+4,089
+0.4% +$162K
IWM icon
29
iShares Russell 2000 ETF
IWM
$79.8B
$46.3M 1.03%
209,591
-11,598
-5% -$2.53M
EVR icon
30
Evercore
EVR
$12.4B
$45M 1%
341,730
-161,446
-32% -$19.7M
MATW icon
31
Matthews International
MATW
$866M
$45M 1%
1,136,915
-51,409
-4% -$1.81M
THS
32
DELISTED
Treehouse Foods
THS
$44.8M 1%
858,260
-34,969
-4% -$1.65M
FCN icon
33
FTI Consulting
FCN
$4.4B
$44.8M 1%
319,553
+14,651
+5% +$1.74M
KBR icon
34
KBR
KBR
$4.62B
$43.4M 0.97%
1,131,787
+89,000
+9% +$2.84M
NVRI icon
35
Enviri
NVRI
$623M
$43.2M 0.96%
2,517,449
-159,948
-6% -$2.9M
HLF icon
36
Herbalife
HLF
$1.29B
$42.4M 0.94%
956,786
-48,057
-5% -$2.37M
USX
37
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$41.8M 0.93%
3,559,122
+13,916
+0.4% +$128K
FLWS icon
38
1-800-Flowers.com
FLWS
$250M
$41.7M 0.93%
1,509,170
-51,624
-3% -$1.53M
SONO icon
39
Sonos
SONO
$1.73B
$41.2M 0.92%
1,100,706
-474,768
-30% -$16M
BKU icon
40
Bankunited
BKU
$3.37B
$40.5M 0.9%
921,995
-82,977
-8% -$3.41M
TCF
41
DELISTED
TCF Financial Corporation Common Stock
TCF
$40.4M 0.9%
870,048
-48,843
-5% -$2.16M
SBNY
42
DELISTED
Signature Bank
SBNY
$39.3M 0.88%
173,937
-45,802
-21% -$9.02M
TCBI icon
43
Texas Capital Bancshares
TCBI
$4.3B
$38.4M 0.85%
541,029
+52,080
+11% +$3.83M
STAG icon
44
STAG Industrial
STAG
$7.38B
$38M 0.85%
1,130,480
-11,791
-1% -$376K
NOVT icon
45
Novanta
NOVT
$5.08B
$37.8M 0.84%
286,622
-6,102
-2% -$802K
QDEL icon
46
QuidelOrtho
QDEL
$1.14B
$37.2M 0.83%
291,081
-4,187
-1% -$773K
BDC icon
47
Belden
BDC
$4.85B
$36.9M 0.82%
831,017
-112,543
-12% -$5.12M
CUBI icon
48
Customers Bancorp
CUBI
$2.66B
$36.7M 0.82%
1,152,786
+5,743
+0.5% +$151K
NUS icon
49
Nu Skin
NUS
$252M
$36.7M 0.82%
693,268
+64,065
+10% +$3.49M
HQY icon
50
HealthEquity
HQY
$8.41B
$36.5M 0.81%
536,993
+61,243
+13% +$4.81M

Similar funds

Aristotle Capital Boston's Q1 2021 Portfolio in Review

As of Q1 2021, Aristotle Capital Boston held 140 positions worth $4.49B, up 6.5% from $4.22B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Aristotle Capital Boston withdrew a net $202M in Q1 2021, closing 3 positions and reducing 95 holdings. Its most notable exit was QEP RESOURCES, INC., an estimated $3.66M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in eHealth worth $24.6M.

  • Aristotle Capital Boston's largest Q1 2021 buy was eHealth: 338,806 shares worth $24.6M.
  • Aristotle Capital Boston added most to Coherus Oncology in Q1 2021, an estimated $5.41M increase.
  • Aristotle Capital Boston's biggest Q1 2021 reduction was Evercore, cutting an estimated $19.7M.
  • Aristotle Capital Boston fully exited QEP RESOURCES, INC. in Q1 2021, selling an estimated $3.66M.
  • Aristotle Capital Boston's ten largest holdings make up 17% of its $4.49B portfolio in Q1 2021.
  • Aristotle Capital Boston opened 5 new positions and closed 3 in Q1 2021.
  • Aristotle Capital Boston's portfolio value rose 6.5% quarter-over-quarter to $4.49B.

Based on Aristotle Capital Boston's 13F filing for Q1 2021, filed 17 May 2021.